CDD-1653

N/A

Report date: 2023/02/02 09:21:12
NME

Base Information

Drug NameCDD-1653
Drug Alias NameCDD-1653CDD1653
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone morphogenetic protein receptor type-2 modulators
TargetsBone morphogenetic protein receptor type-2
Therapy Area/IndicationsMusculoskeletal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesBaylor College Of Medicine
Inactive CompaniesN/A
Active IndicationsMusculoskeletal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A